Tag: oncology molecular diagnostics market analysis

  • Insights Into The Oncology Molecular Diagnostics Market’s Growth Potential 2024-2033

    Insights Into The Oncology Molecular Diagnostics Market’s Growth Potential 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate is Forecasted for the Oncology Molecular Diagnostics Market over the 2024-2033 Period?

    The expansion of the oncology molecular diagnostics market has been swift in the preceding years. The size of the market is projected to increase from $4.19 billion in 2023 to $4.84 billion in 2024 with a compound annual growth rate (CAGR) of 15.6%. The growth witnessed during the historical period is credited to the introduction of early tests in the market, advancements in genomic profiling, the onslaught of next-generation sequencing (NGS), identification of biomarkers at an early stage, and the creation of targeted therapies.

    In the coming years, the market size for oncology molecular diagnostics is projected to witness significant expansion, with an anticipated value of $7.99 billion by 2028, growing at a compound annual growth rate (CAGR) of 13.3%. The anticipated growth during this forecast period is linked to advancements in liquid biopsy, the emergence of companion diagnostics, the incorporation of artificial intelligence (AI), the broadening of ngs applications, and the ongoing evolution of biomarker identification. Key trends predicted for this period consist of worldwide accessibility, the discovery and verification of biomarkers, fine-tuning of the regulatory framework, advancements in technological platforms, and a shift towards patient-centric care models.

    Claim Your Free Sample of the Global Oncology Molecular Diagnostics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

    Which Factors Are Stimulating Growth in the oncology molecular diagnostics Market?

    The surge in global cancer cases is foreseen to propel the expansion of the oncology molecular diagnostics market. The American Cancer Society reported that in 2021, the USA witnessed 1.8 million novel cases and 0.6 million deaths due to cancer. Four predominant types of cancer across the world -lung, prostate, bowel, and female breast, comprise 43% of all fresh cancer diagnoses. Consequently, the escalating global cancer incidence rate is poised to enhance the demand for the oncology molecular diagnostics market in the upcoming years.

    What Are the Main Segments of the Oncology Molecular Diagnostics Market?

    1) By Product: Instruments, Reagents, Other Products

    2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies

    3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

    What Innovative Trends Are Redefining the Oncology Molecular Diagnostics Landscape?

    Order Now for Fast Delivery of Your Oncology Molecular Diagnostics Market Report!

    https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

    Which Regions Are Key Players in the Growth of the Oncology Molecular Diagnostics Market?

    North America was the largest region in the oncology molecular diagnostics market in 2023. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Oncology Molecular Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oncology molecular diagnostics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Oncology Molecular Diagnostics Market Include

    1. Oncology Molecular Diagnostics Market Executive Summary

    2. Oncology Molecular Diagnostics Market Segments

    3. Oncology Molecular Diagnostics Market Size And Template Market Growth Rate

    4. Key Oncology Molecular Diagnostics Market Trends

    5. Major Oncology Molecular Diagnostics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

    26. Top Oncology Molecular Diagnostics Companies

    27. Oncology Molecular Diagnostics Market Opportunities And Strategies

    28. Oncology Molecular Diagnostics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Medical And Diagnostic Laboratory Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

    Medical Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

    Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Oncology Molecular Diagnostics Market Expected To Grow Through 2024-2033

    How Is The Oncology Molecular Diagnostics Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Oncology Molecular Diagnostics Global Market Report 2024, the oncology molecular diagnostics market is expected to show promising growth in the forecast period.

    The oncology molecular diagnostics market is experiencing substantial growth, driven by various factors:

    • Market Size Boom: From $4.19 billion in 2023 to an estimated $4.84 billion in 2024, marking a 15.6% compound annual growth rate (CAGR).
    • Historic Growth Drivers: Early test market entries, genomic profiling advancements, introduction of NGS, early biomarker identification, and targeted therapies development.
    • Forecasted Growth: Expected to reach $7.99 billion by 2028 with a CAGR of 13.3%, fueled by liquid biopsy advancements, rise of companion diagnostics, AI integration, expanded NGS applications, and evolving biomarker identification.

    Revolutionizing Oncology Molecular Diagnostics Through Advanced Genomics Technology

    The integration of advanced genomics technology reshapes the landscape of oncology molecular diagnostics:

    • Technological Advancements: Progress in cancer genome sequencing technology, computational analysis, tumor models, and modern research methods enable early cancer detection and mutation analysis.
    • FDA Approval: Thermo Fisher Scientific Inc.’s FDA-approved NGS-based companion diagnostic test for non-small cell lung cancer patients demonstrates the practical application of advanced genomics in treatment decisions.

    View More On The Oncology Molecular Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

    Healthcare Global Enterprises Limited Strengthens Oncology Diagnostics And Research Capabilities Through Acquisition Of Strand Lifesciences’ Hospital Labs And Clinical Trial Business

    The strategic move by Healthcare Global Enterprises Limited bolsters its oncology diagnostics and research capabilities:

    • Acquisition Impact: HCG’s acquisition of Strand Lifesciences’ Oncology hospital labs and clinical trial business enhances in-house diagnostic and research capabilities.
    • Market Segments: The oncology molecular diagnostics market is segmented by product, technology, and end user, including instruments, reagents, PCR, ISH, sequencing, hospitals, diagnostic centers, and more.
    • Regional Dominance: North America emerged as the largest region in the oncology molecular diagnostics market in 2023, reflecting the region’s advanced healthcare infrastructure and R&D investments.

    Conclusion

    The oncology molecular diagnostics market’s rapid expansion is propelled by technological innovations, rising cancer incidence rates, and strategic acquisitions. As companies continue to invest in advanced genomics, AI integration, and global accessibility, the future promises improved patient outcomes through early detection, personalized therapies, and enhanced research capabilities. With the oncology molecular diagnostics market poised for continued growth, stakeholders must adapt to evolving trends and regulatory frameworks to capitalize on emerging opportunities and address the pressing healthcare challenges posed by cancer.

    Request A Sample Of The Global Oncology Molecular Diagnostics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=3457&type=smp